Clinical trial
Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and…
NCT02307279 · Gelesis, Inc., Industry · Completed
Key facts
| NCT number | NCT02307279 |
|---|---|
| Title | Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes |
| Lead sponsor | Gelesis, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Overweight, Obesity |
| Intervention type | Device |
| Interventions | Gelesis100, placebo |
| Enrollment | 436 |
| Start date | Nov 1, 2014 |
| Primary completion | Jun 1, 2017 |
| Completion | Jun 1, 2017 |
| First posted | Dec 4, 2014 |
| Last update posted | Aug 30, 2022 |
| Countries | Canada, Czechia, Denmark, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: